Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-24

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved olmesartan medoxomil as a generic antihypertensive drug for hypertension under an Original Application to Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)